{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:18:19Z","timestamp":1790014699845,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00467-016-3334-4","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T21:01:13Z","timestamp":1458334873000},"page":"2223-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Diuretics in the treatment of hypertension"],"prefix":"10.1007","volume":"31","author":[{"given":"Douglas L.","family":"Blowey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"3334_CR1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507\u2013520","journal-title":"JAMA"},{"key":"3334_CR2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","volume":"56","author":"JM Flack","year":"2010","unstructured":"Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA, International Society on Hypertension in Blacks (2010) Management of high blood pressure in blacks: an update of the international society on hypertension in blacks consensus statement. Hypertension 56:780\u2013800","journal-title":"Hypertension"},{"key":"3334_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1715163514535341","volume":"147","author":"SK Houle","year":"2014","unstructured":"Houle SK, Padwal R, Poirier L, Tsuyuki RT (2014) The 2014 Canadian hypertension education program (CHEP) guidelines for pharmacists: an update. Can Pharm J 147:203\u2013208","journal-title":"Can Pharm J"},{"key":"3334_CR4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","volume":"21","author":"JA Whitworth","year":"2003","unstructured":"Whitworth JA, World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983\u20131992","journal-title":"J Hypertens"},{"key":"3334_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2014.868629","volume":"23","author":"G Mancia","year":"2014","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology (2014) 2013 ESH\/ESC practice guidelines for the management of arterial hypertension. Blood Press 23:3\u201316","journal-title":"Blood Press"},{"key":"3334_CR6","volume-title":"Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34","author":"National Clinical Guideline Centre","year":"2011","unstructured":"National Clinical Guideline Centre (2011) Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34. National Institute for Health and Clinical Excellence: Guidance, London"},{"key":"3334_CR7","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981\u20132997","journal-title":"JAMA"},{"key":"3334_CR8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206\u20131252","journal-title":"Hypertension"},{"key":"3334_CR9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(79)92278-5","volume":"2","author":"B Jones","year":"1979","unstructured":"Jones B, Nanra RS (1979) Double-blind trial of antihypertensive effect of chlorothiazide in severe renal failure. Lancet 2:1258\u20131260","journal-title":"Lancet"},{"key":"3334_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","volume":"14","author":"B Dussol","year":"2012","unstructured":"Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y (2012) A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens 14:32\u201337","journal-title":"J Clin Hypertens"},{"key":"3334_CR11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11906-012-0293-4","volume":"14","author":"F Karadsheh","year":"2012","unstructured":"Karadsheh F, Weir MR (2012) Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease. Curr Hypertens Rep 14:416\u2013420","journal-title":"Curr Hypertens Rep"},{"key":"3334_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jash.2012.07.004","volume":"6","author":"R Agarwal","year":"2012","unstructured":"Agarwal R, Sinha AD (2012) Thiazide diuretics in advanced chronic kidney disease. J Am Soc Hypertens 6:299\u2013308","journal-title":"J Am Soc Hypertens"},{"key":"3334_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000355135","volume":"38","author":"DJ Taber","year":"2013","unstructured":"Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE (2013) Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol 38:285\u2013291","journal-title":"Am J Nephrol"},{"key":"3334_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1751-7176.2010.00397.x","volume":"13","author":"AH Gradman","year":"2011","unstructured":"Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of Hypertension Writing Group (2011) Combination therapy in hypertension. J Clin Hypertens 13:146\u2013154","journal-title":"J Clin Hypertens"},{"issue":"2 Suppl 4th Rep","key":"3334_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555\u2013576","journal-title":"Pediatrics"},{"key":"3334_CR16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","volume":"27","author":"E Lurbe","year":"2009","unstructured":"Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wuhl E, Zanchetti A, European Society of Hypertension (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719\u20131742","journal-title":"J Hypertens"},{"key":"3334_CR17","volume":"5","author":"VM Musini","year":"2014","unstructured":"Musini VM, Nazer M, Bassett K, Wright JM (2014) Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev 5, CD003824","journal-title":"Cochrane Database Syst Rev"},{"key":"3334_CR18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","volume":"300","author":"JE Carlsen","year":"1990","unstructured":"Carlsen JE, Kober L, Torp-Pedersen C, Johansen P (1990) Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 300:975\u2013978","journal-title":"BMJ"},{"key":"3334_CR19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","volume":"59","author":"MA Peterzan","year":"2012","unstructured":"Peterzan MA, Hardy R, Chaturvedi N, Hughes AD (2012) Meta-analysis of dose\u2013response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension 59:1104\u20131109","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"3334_CR20","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/sj.jhh.1001349","volume":"16","author":"AJ Reyes","year":"2002","unstructured":"Reyes AJ (2002) Diuretics in the therapy of hypertension. J Hum Hypertens 16(Suppl 1):S78\u2013S83","journal-title":"J Hum Hypertens"},{"key":"3334_CR21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00467-002-0851-0","volume":"17","author":"JM Sorof","year":"2002","unstructured":"Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ (2002) Beta-blocker\/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol 17:345\u2013350","journal-title":"Pediatr Nephrol"},{"key":"3334_CR22","unstructured":"Bachmann H (1984) Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension. Helv Paediatr Acta 39:55\u201361"},{"key":"3334_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000441-199002000-00001","volume":"299","author":"GS Berenson","year":"1990","unstructured":"Berenson GS, Shear CL, Chiang YK, Webber LS, Voors AW (1990) Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood. J Med Sci 299:79\u201386","journal-title":"J Med Sci"},{"key":"3334_CR24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","volume":"64","author":"N Vasavada","year":"2003","unstructured":"Vasavada N, Agarwal R (2003) Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. Kidney Int 64:1772\u20131779","journal-title":"Kidney Int"},{"key":"3334_CR25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1523-1755.2003.00124.x","volume":"64","author":"N Vasavada","year":"2003","unstructured":"Vasavada N, Saha C, Agarwal R (2003) A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int 64:632\u2013640","journal-title":"Kidney Int"},{"key":"3334_CR26","first-page":"RA79","volume":"16","author":"M Zaffanello","year":"2010","unstructured":"Zaffanello M, Cataldi L, Franchini M, Fanos V (2010) Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. Med Sci Monit 16:RA79\u2013RA84","journal-title":"Med Sci Monit"},{"key":"3334_CR27","first-page":"213","volume":"60","author":"P Tanphaichitr","year":"1977","unstructured":"Tanphaichitr P (1977) Oral furosemide versus conventional therapy for acute poststreptococcal glomerulonephritis in children. J Med Assoc Thail 60:213\u2013217","journal-title":"J Med Assoc Thail"},{"key":"3334_CR28","volume":"8","author":"VM Musini","year":"2012","unstructured":"Musini VM, Rezapour P, Wright JM, Bassett K, Jauca CD (2012) Blood pressure lowering efficacy of loop diuretics for primary hypertension. Cochrane Database Syst Rev 8, CD003825","journal-title":"Cochrane Database Syst Rev"},{"key":"3334_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH, Roniker B, Krause SL, Weiss RJ (2002) Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 15:709\u2013716","journal-title":"Am J Hypertens"},{"issue":"1 Suppl 1","key":"3334_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1524-6175.2007.06334.x","volume":"9","author":"DA Calhoun","year":"2007","unstructured":"Calhoun DA (2007) Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. J Clin Hypertens 9(1 Suppl 1):19\u201324","journal-title":"J Clin Hypertens"},{"key":"3334_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR, Anglo-Scandinavian Cardiac Outcomes Trial Investigators (2007) Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839\u2013845","journal-title":"Hypertension"},{"key":"3334_CR32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","volume":"25","author":"DA Lane","year":"2007","unstructured":"Lane DA, Shah S, Beevers DG (2007) Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J Hypertens 25:891\u2013894","journal-title":"J Hypertens"},{"key":"3334_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpeds.2010.02.042","volume":"157","author":"JS Li","year":"2010","unstructured":"Li JS, Flynn JT, Portman R, Davis I, Ogawa M, Shi H, Pressler ML (2010) The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose\u2013response study. J Pediatr 157:282\u2013287","journal-title":"J Pediatr"},{"key":"3334_CR34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14656566.2014.879118","volume":"15","author":"J Tamargo","year":"2014","unstructured":"Tamargo J, Segura J, Ruilope LM (2014) Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics. Expert Opin Pharmacother 15:527\u2013547","journal-title":"Expert Opin Pharmacother"},{"key":"3334_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","volume":"31","author":"DC Brater","year":"2011","unstructured":"Brater DC (2011) Update in diuretic therapy: clinical pharmacology. Semin Nephrol 31:483\u2013494","journal-title":"Semin Nephrol"},{"key":"3334_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/14656566.2014.879117","volume":"15","author":"J Tamargo","year":"2014","unstructured":"Tamargo J, Segura J, Ruilope LM (2014) Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents. Expert Opin Pharmacother 15:605\u2013621","journal-title":"Expert Opin Pharmacother"},{"key":"3334_CR37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","volume":"47","author":"ME Ernst","year":"2006","unstructured":"Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR (2006) Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352\u2013358","journal-title":"Hypertension"},{"key":"3334_CR38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/HYPERTENSIONAHA.111.181248","volume":"58","author":"ME Ernst","year":"2011","unstructured":"Ernst ME, Neaton JD, Grimm RH Jr, Collins G, Thomas W, Soliman EZ, Prineas RJ, Multiple Risk Factor Intervention Trial Research Group (2011) Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 58:1001\u20131007","journal-title":"Hypertension"},{"key":"3334_CR39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/HCO.0b013e3283622075","volume":"28","author":"GC Roush","year":"2013","unstructured":"Roush GC, Buddharaju V, Ernst ME (2013) Is chlorthalidone better than hydrochlorothiazide in reducing cardiovascular events in hypertensives? Curr Opin Cardiol 28:426\u2013432","journal-title":"Curr Opin Cardiol"},{"key":"3334_CR40","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","volume":"59","author":"GC Roush","year":"2012","unstructured":"Roush GC, Holford TR, Guddati AK (2012) Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 59:1110\u20131117","journal-title":"Hypertension"},{"key":"3334_CR41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","volume":"8","author":"JD Duarte","year":"2010","unstructured":"Duarte JD, Cooper-DeHoff RM (2010) Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther 8:793\u2013802","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"3334_CR42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.CIR.20.6.1028","volume":"20","author":"IM Wilson","year":"1959","unstructured":"Wilson IM, Freis ED (1959) Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20:1028\u20131036","journal-title":"Circulation"},{"key":"3334_CR43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.CIR.41.4.709","volume":"41","author":"RC Tarazi","year":"1970","unstructured":"Tarazi RC, Dustan HP, Frohlich ED (1970) Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation 41:709\u2013717","journal-title":"Circulation"},{"key":"3334_CR44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.1980.44","volume":"27","author":"P Brummelen van","year":"1980","unstructured":"van Brummelen P, Man In't Veld AJ, Schalekamp MA (1980) Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther 27:328\u2013336","journal-title":"Clin Pharmacol Ther"},{"key":"3334_CR45","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.HYP.37.6.1458","volume":"37","author":"DN Cruz","year":"2001","unstructured":"Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP (2001) Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 37:1458\u20131464","journal-title":"Hypertension"},{"key":"3334_CR46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1681\/ASN.2005030314","volume":"17","author":"J Hadchouel","year":"2006","unstructured":"Hadchouel J, Delaloy C, Faure S, Achard JM, Jeunemaitre X (2006) Familial Hyperkalemic hypertension. J Am Soc Nephrol 17:208\u2013217","journal-title":"J Am Soc Nephrol"},{"key":"3334_CR47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.118","volume":"40","author":"W Ji","year":"2008","unstructured":"Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP (2008) Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40:592\u2013599","journal-title":"Nat Genet"},{"key":"3334_CR48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.HYP.0000186240.81996.57","volume":"46","author":"ST Turner","year":"2005","unstructured":"Turner ST, Schwartz GL, Chapman AB, Boerwinkle E (2005) WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 46:758\u2013765","journal-title":"Hypertension"},{"key":"3334_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1378\/chest.56.1.43","volume":"56","author":"WB Kannel","year":"1969","unstructured":"Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest 56:43\u201352","journal-title":"Dis Chest"},{"key":"3334_CR50","volume":"3","author":"JM Wright","year":"2009","unstructured":"Wright JM, Musini VM (2009) First-line drugs for hypertension. Cochrane Database Syst Rev 3, CD001841","journal-title":"Cochrane Database Syst Rev"},{"key":"3334_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/IBPC.S34792","volume":"6","author":"JW Cheng","year":"2013","unstructured":"Cheng JW (2013) Azilsartan\/chlorthalidone combination therapy for blood pressure control. Integr Blood Press Control 6:39\u201348","journal-title":"Integr Blood Press Control"},{"key":"3334_CR52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","volume":"248","author":"Multiple Risk Factor Intervention Trial Research Group","year":"1982","unstructured":"Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 248:1465\u20131477","journal-title":"JAMA"},{"key":"3334_CR53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","volume":"57","author":"MP Dorsch","year":"2011","unstructured":"Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB (2011) Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 57:689\u2013694","journal-title":"Hypertension"},{"key":"3334_CR54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/14740330903499257","volume":"9","author":"PA Sarafidis","year":"2010","unstructured":"Sarafidis PA, Georgianos PI, Lasaridis AN (2010) Diuretics in clinical practice. Part II: electrolyte and acid\u2013base disorders complicating diuretic therapy. Expert Opin Drug Saf 9:259\u2013273","journal-title":"Expert Opin Drug Saf"},{"key":"3334_CR55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.amjmed.2014.04.014","volume":"127","author":"JC Blijderveen van","year":"2014","unstructured":"van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH, Sturkenboom MC, Verhamme KM (2014) Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide. Am J Med 127:763\u2013771","journal-title":"Am J Med"},{"key":"3334_CR56","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","volume":"330","author":"DS Siscovick","year":"1994","unstructured":"Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Copass MK, Wagner EH (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330:1852\u20131857","journal-title":"N Engl J Med"},{"key":"3334_CR57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2796.1989.tb01383.x","volume":"226","author":"A Sjogren","year":"1989","unstructured":"Sjogren A, Edvinsson L, Fallgren B (1989) Magnesium deficiency in coronary artery disease and cardiac arrhythmias. J Intern Med 226:213\u2013222","journal-title":"J Intern Med"},{"key":"3334_CR58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","volume":"369","author":"WJ Elliott","year":"2007","unstructured":"Elliott WJ, Meyer PM (2007) Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369:201\u2013207","journal-title":"Lancet"},{"key":"3334_CR59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004576","volume":"4","author":"S Ueda","year":"2014","unstructured":"Ueda S, Morimoto T, Ando S, Takishita S, Kawano Y, Shimamoto K, Ogihara T, Saruta T, Investigators DIME (2014) A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: diuretics in the management of essential hypertension (DIME) study. BMJ Open 4, e004576","journal-title":"BMJ Open"},{"key":"3334_CR60","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","volume":"349","author":"BL Strom","year":"2003","unstructured":"Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D (2003) Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 349:1628\u20131635","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3334-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3334-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3334-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3334-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T16:12:45Z","timestamp":1655309565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3334-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3334"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3334-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]}}}